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No ups or downs for keratin
Mutations in keratin 5 (KRT5) have previously been identi-
fied in patients with epidermolysis bullosa simplex (EBS), 
a blistering skin disease. These mutations produce aberrant 
proteins with a dominant-negative effect. Recently, identi-
fication of loss-of-function mutations in KRT5 in Dowling-
Degos disease (DDD), an autosomal dominant reticulate 
pigmentary disorder, indicated that downregulation of ker-
atin also prevents proper skin homeostasis. Betz and col-
leagues examined DNA samples from German families with 
DDD and uncovered mutations that resulted in premature 
termination of the keratin 5 protein. One such mutation 
(frameshift at Ile140), which was found in multiple patients, 
resulted in normal mRNA levels and in histology similar to 
that of EBS cells; however, this mutated protein localized 
with dynein at the nuclear periphery and failed to be incor-
porated into the intermediate filament network. Thus, these 
results demonstrated that keratin is crucial for cell adhe-
sion, melanosome uptake, organelle transport, and nuclear 
anchorage. (Am J Hum Genet 78:510–9, 2006)
Langerhans cells stopped in their tracks
Histology indicates that psoriatic plaques exhibit abnormal 
proliferation and differentiation of epidermal keratinocytes. 
The current dogma suggests that this disease is directly 
mediated by T cells. Langerhans cells (LCs), a population 
of dendritic cells that reside in the epidermis, have been 
implicated, as these cells traffic antigens to T cells. Thus, 
Cumberbatch and colleagues recently investigated the role 
of LCs in psoriasis. The level and morphology of LCs in the 
unaffected skin of psoriasis patients were similar to those 
in normal skin. Treatment with a contact allergen, IL-1β, 
or tumor necrosis factor-α failed to induce LC migration to 
local draining lymph nodes in psoriatic skin as in normal 
skin. Interestingly, the levels of cytokines and their recep-
tors in the psoriatic cells were normal. Thus, the function 
of LCs is clearly impaired in psoriasis patients, although the 
molecular mechanism remains to be elucidated. (J Exp Med 
203:953–60, 2006)
Metals disrupt peptide interactions
Class II major histocompatibility complex (MHC) proteins 
are essential not only for everyday immune function but also 
for autoimmune reactions. These molecules serve to bind 
antigen for the activation of T cells. Fortuitously for disease 
protection, peptide binding is strong, and dissociation is 
slow. Using a high-throughput screen of 28,000 compounds, 
De Wall and colleagues identified several noble-metal 
complexes, including platinum, palladium, and gold com-
plexes, that could actually disrupt the interaction between 
peptide and MHC DR1 molecules. The metal:MHC com-
plexes assumed the conformation of an empty peptide-bind-
ing site. Strikingly, biochemical experiments demonstrated 
that this action, which proved to be independent of peptide 
sequence, worked through an allosteric mechanism. Finally, 
metal binding prevented T-cell activation by the MHC-bear-
ing antigen-presenting cells. These exciting data demonstrate 
that noble metals are capable of exerting a T cell-mediating 
effect, and thus, metal complexes should be explored for the 
development of drugs targeting autoimmune diseases such 
as rheumatoid arthritis. (Nat Chem Biol 2:197–201, 2006)
Innate defenses work against smallpox 
vaccine
The threat of bioterrorism propels the reality of smallpox 
vaccination to the forefront of the medical community. 
Vaccination with vaccinia virus (VV) remains the only safe 
and effective mechanism to immunize patients against small-
pox, but this anaphylaxis proves dangerous to vast numbers 
of atopic dermatitis (AD) patients, who develop eczema 
vaccinatum in response to the vaccine. Understanding the 
mechanisms of this reaction is crucial for developing treat-
ment in the event of a smallpox outbreak. Recently, Howell 
and colleagues showed that viral replication was increased 
concomitantly with a decrease in the antimicrobial peptide 
LL-37 in AD skin. These cells commonly overexpress IL-4 
and IL-13. Interestingly, blocking these cytokines with neu-
tralizing antibodies decreased viral replication and promot-
ed LL-37 expression, demonstrating that innate defenses play 
a role in containing VV after inoculation. These results open 
the door for new therapies targeting these Th2 cytokines 
as a means to allow smallpox vaccination in AD patients. 
(Immunity 24:341–8, 2006)
Putting the academic house in order
Proper medical care may be jeopardized by relation-
ships between pharmaceutical companies and physicians. 
Pharmaceutical and medical-device companies commonly 
provide small gifts, free product samples, continuing medi-
cal education opportunities, and travel subsidies in order to 
promote their products and earn time with busy physicians. 
While those in the medical profession do not intend to alter 
their advice based on these provisions, research indicates 
the potential for reciprocation by the physicians. Thus, oppo-
nents argue for more stringent policing of these relationships. 
Brennan and colleagues recently called on academic medi-
cal centers, where the vast majority of training and research 
occurs, to serve as role models for the entire medical com-
munity by prohibiting all gifts and strictly monitoring and 
disclosing the contracts between researchers and industry. 
(JAMA 295:429–33, 2006)
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